Kala Pharmaceuticals Valuation
| KALA Stock | USD 6.92 0.12 1.76% |
At this time, the firm appears to be fairly valued. Kala Pharmaceuticals secures a last-minute Real Value of $6.87 per share. The latest price of the firm is $6.92. Our model forecasts the value of Kala Pharmaceuticals from analyzing the firm fundamentals such as Shares Owned By Insiders of 4.12 %, return on equity of -4.31, and Current Valuation of 29.99 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kala Pharmaceuticals' valuation include:
Price Book 6.1454 | Enterprise Value | Enterprise Value Ebitda (0.16) | Price Sales 1.157 | Enterprise Value Revenue 0.0421 |
Fairly Valued
Today
Please note that Kala Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Kala Pharmaceuticals is based on 3 months time horizon. Increasing Kala Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kala Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kala Stock. However, Kala Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.92 | Real 6.87 | Target 15.0 | Hype 6.92 | Naive 7.46 |
The real value of Kala Stock, also known as its intrinsic value, is the underlying worth of Kala Pharmaceuticals Company, which is reflected in its stock price. It is based on Kala Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kala Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Kala Pharmaceuticals helps investors to forecast how Kala stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kala Pharmaceuticals more accurately as focusing exclusively on Kala Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kala Pharmaceuticals' intrinsic value based on its ongoing forecasts of Kala Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kala Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Kala Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Kala Pharmaceuticals Cash |
|
Kala Valuation Trend
Comparing Kala Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Kala Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Kala Pharmaceuticals Total Value Analysis
Kala Pharmaceuticals is now expected to have valuation of 29.99 M with market capitalization of 42.15 M, debt of 36.32 M, and cash on hands of 44.57 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Kala Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.99 M | 42.15 M | 36.32 M | 44.57 M |
Kala Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Kala is to check how much profit was generated for every dollar of assets it reports. Kala Pharmaceuticals secures a negative usage of assets of -0.44 %, losing $0.004375 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Kala Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Kala Pharmaceuticals Ownership Allocation
The market capitalization of Kala Pharmaceuticals is $42.15 Million. Over half of Kala Pharmaceuticals' outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Kala Pharmaceuticals Profitability Analysis
Net Loss for the year was (42.2 M) with profit before overhead, payroll, taxes, and interest of 1.33 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kala Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kala Pharmaceuticals and how it compares across the competition.
About Kala Pharmaceuticals Valuation
The stock valuation mechanism determines Kala Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Kala Pharmaceuticals. We calculate exposure to Kala Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kala Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -348.4 K | -331 K | |
| Pretax Profit Margin | (10.36) | (10.88) | |
| Operating Profit Margin | (18.81) | (19.75) | |
| Net Loss | (0.05) | (0.05) | |
| Gross Profit Margin | 0.39 | 0.59 |
Kala Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.4 M |
Kala Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Kala Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Kala we look at many different elements of the entity such as Kala's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kala Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kala Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kala Pharmaceuticals' worth.Complementary Tools for Kala Stock analysis
When running Kala Pharmaceuticals' price analysis, check to measure Kala Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kala Pharmaceuticals is operating at the current time. Most of Kala Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kala Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kala Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kala Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |